Advertisement

Topics

Prokarium Company Profile

23:13 EDT 19th April 2018 | BioPortfolio


News Articles [12 Associated News Articles listed on BioPortfolio]

Prokarium raises $10m for 'game changer' synthetic bio vaccines

UK company Prokarium has raised $10 million to develop groundbreaking synthetic biology techniques to create a new generation of vaccines, which could be taken orally, and not have to be kept in a ref...

Prokarium secures $10M to advance thermostable vaccines study

Prokarium raised $10 million from Korean, Saudi and Swedish investors to advance clinical development of vaccines against chl -More- 

Prokarium raises $10m for thermostable vaccines

UK-based synthetic biology firm Prokarium has secured $10 million from Saudi, Swedish and Korean investors to help drive clinical development of thermostable vaccines.

Series B lands $10mm for Prokarium

Synthetic biology firm Prokarium raised $10mm in its Series B financing round led by the Riyadh Valley Co., which was joined by Flerie Invest and Korea Investment Partners.

Prokarium secures $10 million for thermostable vaccine development

Prokarium, a UK-based synthetic biology company and developer of Vaxonella, an oral, thermostable vaccine delivery platform, announced the completion of a $10 million investment round

Prokarium raises $10 million for clinical development of thermostable vaccines

UK-based synthetic biology company, Prokarium, has completed an investment round, raising $10 million for the clinical development of vaccines against chlamydia, C.difficile and enteric fever, plus an...

This Oral Vaccine for Typhoid Raises €8M from International Investors

Prokarium has raised $10M (€8M) from Saudi, Swedish and Korean investors to support the clinical development of its oral vaccines for infectious diseases like typhoid. Since its foundation in 2012, ...

Prokarium Secures $10 Million Investment from Saudi, Swedish and Korean Investors for Clinical Development of Revolutionary Thermostable Vaccines

Prokarium, the UK-based synthetic biology company that has developed Vaxonella, an oral, thermostable vaccine delivery platform, today announced the completion of a $10 mil...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "Prokarium" on BioPortfolio

We have published hundreds of Prokarium news stories on BioPortfolio along with dozens of Prokarium Clinical Trials and PubMed Articles about Prokarium for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prokarium Companies in our database. You can also find out about relevant Prokarium Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record